Moksha8 Pharmaceuticals, Inc.
Location
Pennsylvania
Founded
2006-03-24
Risk Signals
9 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Moksha8 Pharmaceuticals, Inc.
Live alerts from global media, monitored by Business Radar
2023-09-20 (globenewswire.com)
Acino significantly expands presence and capabilities in Latin America through acquisition of M8 Pharmaceuticals
Over 300 M8 employees, product portfolio and pipeline to enhance Acino's footprint and strategic position in key Latin American markets....
Read more
2021-06-22 (prnewswire.com)
M8 Pharmaceuticals and UCB partner for Central Nervous System and Respiratory Portfolio in Mexico
/PRNewswire/ -- m8 Pharmaceuticals and UCB Mexico, an affiliate of a global pharmaceutical company, have signed an exclusive promotion and commercialization...
Read more
2010-10-04 (genengnews.com)
Watson Invests $30M in Moksha8 and Forms Marketing Partnership for Brazil and Mexico
Watson may invest another $20 million if Moksha8 acquires more products over the next year.
Read more
(businesskorea.co.kr)
Daewoong Pharmaceutical Secures 180 Bil. Won Nabota Export Deal with Moksha8 -
On Feb. 14, Daewoong Pharmaceutical announced a botulinum toxin Nabota export contract worth 180 billion won with its Brazilian partner, Moksha8. This agreemen
Read more
(koreabiomed.com)
Daewoong secures landmark BTX export deal in Latin America < Pharma < Article -
Daewoong Pharmaceutical has signed a 180 billion won ($125 million) botulinum toxin (BTX) export contract with M8 Pharmaceuticals, its partner in Brazil, marking its largest deal in Latin America since entering the market. The five-year agreement, announced Friday, is 10 times the size of Daewoong's
Read more
(medicaldevice-network.com)
M8 to market Futura's erectile dysfunction gel in more countries - Medical Device Network
M8, already with rights to supply Eroxon in Mexico and Brazil, has expanded its licensing agreement with Futura to 14 further countries.
Read more
(prnewswire.com)
M8 Pharmaceuticals and Daewoong Pharmaceutical strengthen their strategic partnership by signing an exclusive licensing agreement for Envlo™ (Enavogliflozin) for Brazil and Mexico
/PRNewswire/ -- M8 Pharmaceuticals and Daewoong Pharmaceuticals announced they have signed an exclusive licensing agreement whereby M8 will have the rights to...
Read more
(prnewswire.com)
M8 Pharmaceuticals obtains market authorization for Barlo® (Carragelose®) nasal spray in Mexico
/PRNewswire/ -- M8 pharmaceuticals is pleased to announce the market approval of a Barlo® (Carragelose®) nasal spray in Mexico. In 2021, Marinomed announced a...
Read more
(prnewswire.com)
Montreux portfolio Company Moksha8 Announces the Appointment of Mariano Garcia-Valiño to its board of directors usa - english Brazil - Português Latin America - Español
/PRNewswire/ -- MOKSHA8, a specialty pharmaceutical company, announces the appointment of Mariano Garcia-Valiño as a Board Member and Chairman of its...
Read more